Clinical Trials Browser

Medulloblastoma × Diphtheria-Tetanus Vaccine × 90 days × Clear all

NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT06514898 2026-04-03

MATCHPOINT

Phase 1 Active not recruiting

Medulloblastoma